Cannabis Suisse Corp (CSUI) fair value: what the stock is really worth
As of Oct 23, 2026: fair value (intrinsic value) of Cannabis Suisse Corp stock $0.01, price $0.01, upside -15.6%, quality 37 out of 100. Rating: overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 23, 2026.
How to read this chart
60‑month range $0.0028 – $0.2254 · fair‑value band $0.0064 – $0.0067 · the $0.0077 price screens above the $0.0065 fair value. Dashed = 300-day average. As of Oct 23, 2026.
Follow Cannabis Suisse in your weekly email
Every Wednesday you see whether Cannabis Suisse is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Cannabis Suisse Corp. engages in the real estate business. It leases commercial office and industrial space. The company was formerly known as Geant Corp. and changed its name to Cannabis Suisse Corp. in February 2019.
Show moreShow less
Cannabis Suisse Corp. was incorporated in 2016 and is based in Jacksonville, Florida.
Stock analysis
Cannabis Suisse Corp (CSUI) currently trades at $0.0077, while our model-based Fair Value estimate is $0.0065, 15.6% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of $0.0600 per share, and 5 of the 5 models we run sit above the $0.0077 price.
Bear case: the Earnings-Based group reads lowest at $0.0600, and 0 of the 5 models stay below the price. Data coverage for this calculation is low.
Scenario range: $0.0064 (bear) to $0.0067 (bull), the price of $0.0077 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 37/100 (below-average quality), in the Real Estate sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Cannabis Suisse Corp reported revenue of $21.0K in FY2026 versus $7.8K in FY2022, a compound +28.2%/yr. Reported net income was $123K in FY2026.
Key figures
Market cap $544K Micro · P/S ratio 13.0 · Return on assets (EBIT) −60.2% · Operating margin −206% · Revenue (TTM) $42.0K · EPS growth (YoY) +279% · Free cash flow −$40.3K · Net debt $1.9M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 21 out of 100 (low confidence).
What moves the price
The share trades about 51% below its 52-week high and 175% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Real Estate peers we cover trades at −12% fair-value upside, at −16%, CSUI screens richer than that median.
Fair Value models
Bear$0.0064Fair Value $0.0065Bull$0.0067
Price $0.0077 · Upside -15.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Growth-Adj P/E$0.0700$0.1000$0.120064
P/E Multiple$0.0500$0.0600$0.080063
Graham-Dodd$0.0100$0.0800$0.120059
All 5 models by family
Earnings-Based
Graham-Dodd$0.0100$0.0800$0.120059
Lynch FV$0.0400$0.0600$0.080057
PEG = 1.0$0.0400$0.0600$0.080053
Multiples
P/E Multiple$0.0500$0.0600$0.080063
Growth Earnings
Growth-Adj P/E$0.0700$0.1000$0.120064
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.19/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−6.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+28.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−16.2%
Start year 2021 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.4%
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−704.0% (2021) → −1,275.3% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Real Estate Services · 524 stocks
Beats the industry median on 1/4 measures
Overall it trails its industry peers.
Valuation
Quality Score37 · Bottom 25%
Fair Value upside−15.6% · Below median
Profitability
Return on equity (12 months)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets30.1% · Top 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Real Estate Services median · lower = cheaper
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (12 months)12.96× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)13· sector 48
FUTURE (revenue growth)0· sector 17
PAST (return on equity)0· sector 17
HEALTH (low debt)0· sector 83
DIVIDEND (yield)0· sector 65
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Cannabis Suisse Corp (CSUI) overvalued or undervalued?
As of Oct 23, 2026, our model estimates a fair value of $0.0065 versus a price of $0.0077, about −16% upside (overvalued).
What is the fair value of CSUI?
Our model-based fair value for Cannabis Suisse Corp is $0.0065 (as of Oct 23, 2026), built from audited fundamentals. The current price: $0.0077.
What is the quality score of CSUI?
Cannabis Suisse Corp has a Quality Score of 37/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cannabis Suisse Corp (CSUI)?
Our model-based price target is the fair value of $0.0065 (as of Oct 23, 2026) from 5 valuation models. Cautious scenario $0.0064, optimistic scenario $0.0067. It is a calculation from audited fundamentals, not an analyst target.
What is the Cannabis Suisse Corp stock forecast for 2026?
Our models put fair value at $0.0065, about −16% upside versus a price of $0.0077 (overvalued). Cautious scenario $0.0064, optimistic scenario $0.0067. The calculation is refreshed regularly with new filings.
What is the revenue of Cannabis Suisse Corp (CSUI)?
Cannabis Suisse Corp reported trailing-twelve-month revenue of about $42.0K (latest available figure, as of Oct 23, 2026).
What is the intrinsic value of Cannabis Suisse Corp (CSUI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cannabis Suisse Corp it is $0.0065 per share (as of Oct 23, 2026), against a price of $0.0077. It is the blended result of 5 valuation models (cash flow, earnings, asset, dividend).
Is Cannabis Suisse Corp stock overvalued or undervalued in 2026?
As of Oct 23, 2026, CSUI trades above its calculated fair value: price $0.0077, fair value $0.0065, a gap of about −16% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CSUI?
No. The price is what the market pays today ($0.0077); the fair value is what the company's own numbers justify ($0.0065). For Cannabis Suisse Corp the two are $0.0012 per share apart. That gap is exactly why we show both numbers side by side.
How much is Cannabis Suisse Corp worth?
The market values Cannabis Suisse Corp at about $544K (market capitalisation, as of Oct 23, 2026). Per share that is $0.0077; our models calculate a fair value of $0.0065 per share.
What do the bullish and bearish scenarios say about CSUI?
Our models span a range for Cannabis Suisse Corp: cautious scenario $0.0064, base $0.0065, optimistic $0.0067 per share (as of Oct 23, 2026, price $0.0077). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Cannabis Suisse Corp (CSUI)?
Balance-sheet figures for Cannabis Suisse Corp (as of Oct 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 37/100, which measures business quality independently of the share price.
How far is CSUI from its 52-week high?
Cannabis Suisse Corp trades at $0.0077, about 51% below its 52-week high of $0.0158 and 175% above the low of $0.0028 (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0065 is for.
Which stocks are comparable to Cannabis Suisse Corp?
From the same area (Real Estate) we also value CBRE Group, Cellnex Telecom, S.A, KE Holdings, Swire Properties Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cannabis Suisse Corp stock attractive at the current price?
The data as of Oct 23, 2026: price $0.0077, calculated fair value $0.0065 (−16%), Quality Score 37/100, from 5 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CSUI calculated?
We run Cannabis Suisse Corp through 5 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0065, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.3 % above its aggregate fair value. Cannabis Suisse Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cannabis Suisse Corp (CSUI)?
The closing price on Oct 23, 2026 was $0.0077. Our model-based fair value is $0.0065, about −16% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cannabis Suisse Corp right now?
The price sits above even our optimistic bull case ($0.0067). The favourable scenario is already priced in. Weak quality (37/100) and above fair value at the same time, the margin of safety is missing on both counts. The models converge in a tight band ($0.0064 to $0.0067), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Cannabis Suisse Corp
How large is the market capitalisation of Cannabis Suisse Corp (CSUI)?
The market capitalisation of Cannabis Suisse Corp is $544K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cannabis Suisse Corp (CSUI)?
The price-to-sales ratio of Cannabis Suisse Corp is 13.0 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the EBIT return on assets of Cannabis Suisse Corp (CSUI)?
On an EBIT basis the return on assets of Cannabis Suisse Corp is −60.2% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cannabis Suisse Corp (CSUI)?
The operating margin of Cannabis Suisse Corp is −206% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast are earnings growing at Cannabis Suisse Corp (CSUI)?
Earnings per share at Cannabis Suisse Corp are growing +279% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Cannabis Suisse Corp (CSUI) generate?
The free cash flow of Cannabis Suisse Corp is −$40.3K (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Cannabis Suisse Corp (CSUI) carry?
The net debt of Cannabis Suisse Corp is $1.9M (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Cannabis Suisse Corp in the live analysis
One click puts Cannabis Suisse Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 23, 2026